- Report
- August 2025
- 180 Pages
Global
From €3976EUR$4,500USD£3,467GBP
- Report
- April 2025
- 184 Pages
Global
From €3976EUR$4,500USD£3,467GBP
- Report
- February 2025
- 185 Pages
Global
From €3976EUR$4,500USD£3,467GBP
- Report
- August 2025
- 183 Pages
Global
From €3976EUR$4,500USD£3,467GBP
- Report
- January 2026
- 271 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- January 2026
- 381 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- January 2026
- 272 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- January 2026
- 193 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- January 2026
- 131 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- January 2026
- 276 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- January 2026
- 258 Pages
Global
From €5168EUR$5,850USD£4,507GBP
- Report
- May 2025
- 106 Pages
Global
From €4196EUR$4,750USD£3,659GBP
- Report
- October 2025
- 144 Pages
Global
From €3533EUR$3,999USD£3,081GBP
- Report
- March 2025
- 145 Pages
Global
From €3533EUR$3,999USD£3,081GBP
- Report
- November 2025
- 150 Pages
Global
From €3313EUR$3,750USD£2,889GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1104EUR$1,250USD£963GBP
- Report
- July 2025
- 350 Pages
Global
From €4372EUR$4,949USD£3,813GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP
- Report
- June 2025
- 150 Pages
Global
From €2384EUR$2,699USD£2,079GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2464EUR$2,789USD£2,149GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more